DAX 30, EU Stoxx 50 May Rise as Investors Await Vaccine Approval

The benchmark DAX 30 and EU Stoxx 50 index may continue to push higher in the near term. However, the elongated wait for vaccine approval may begin to gnaw at market sentiment.

Related Articles

Responses

Your email address will not be published. Required fields are marked *